Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 555

1.
2.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
3.

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.

Aseeri M, Schroeder T, Kramer J, Zackula R.

Am J Gastroenterol. 2008 Sep;103(9):2308-13. doi: 10.1111/j.1572-0241.2008.01975.x. Epub 2008 Aug 12.

PMID:
18702653
4.

Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.

Thipmontree W, Kiratisin P, Manatsathit S, Thamlikitkul V.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S207-16.

PMID:
21721449
5.

Clostridium difficile infection and proton pump inhibitors.

Pohl JF.

Curr Opin Pediatr. 2012 Oct;24(5):627-31. doi: 10.1097/MOP.0b013e328355a3e1. Review.

PMID:
22781139
6.

Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.

Stevens V, Dumyati G, Brown J, Wijngaarden E.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1035-42. doi: 10.1002/pds.2198. Epub 2011 Aug 10.

PMID:
21833992
7.

Clostridium difficile infection in hospitals: risk factors and responses.

Louie TJ, Meddings J.

CMAJ. 2004 Jul 6;171(1):45-6. No abstract available.

8.

Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.

Kaneria MV, Paul S.

J Assoc Physicians India. 2012 Nov;60:26-8.

PMID:
23767199
9.

Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak.

Thibault A, Miller MA, Gaese C.

Infect Control Hosp Epidemiol. 1991 Jun;12(6):345-8.

PMID:
2071877
10.

Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.

Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR.

Mayo Clin Proc. 2013 Oct;88(10):1085-90. doi: 10.1016/j.mayocp.2013.07.004. Epub 2013 Sep 5.

PMID:
24012413
11.

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S.

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

12.

Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.

Hassan SA, Rahman RA, Huda N, Wan Bebakar WM, Lee YY.

J R Coll Physicians Edinb. 2013;43(2):103-7. doi: 10.4997/JRCPE.2013.203.

PMID:
23734349
13.
14.

Host and pathogen factors for Clostridium difficile infection and colonization.

Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, Toye B, Beaudoin A, Frost EH, Gilca R, Brassard P, Dendukuri N, Béliveau C, Oughton M, Brukner I, Dascal A.

N Engl J Med. 2011 Nov 3;365(18):1693-703. doi: 10.1056/NEJMoa1012413.

15.

Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.

Leonard AD, Ho KM, Flexman J.

Intern Med J. 2012 May;42(5):591-4. doi: 10.1111/j.1445-5994.2012.02770.x.

PMID:
22616966
16.

Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea.

Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J.

Infect Control Hosp Epidemiol. 2007 Apr;28(4):377-81. Epub 2007 Mar 9.

PMID:
17385141
17.

Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy.

Mizui T, Teramachi H, Tachi T, Tamura K, Shiga H, Komada N, Umeda M, Koda A, Aoyama S, Goto C, Tsuchiya T.

Pharmazie. 2013 Aug;68(8):706-10.

PMID:
24020129
18.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ.

Clin Infect Dis. 2007 Nov 1;45(9):1141-51. Epub 2007 Sep 26.

PMID:
17918075
19.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L.

Clin Infect Dis. 2005 Nov 1;41(9):1254-60. Epub 2005 Sep 20.

PMID:
16206099
20.

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D.

CMAJ. 2004 Aug 31;171(5):466-72.

Supplemental Content

Support Center